Format

Send to

Choose Destination
See comment in PubMed Commons below
Regen Med. 2012 Nov;7(6 Suppl):100-3. doi: 10.2217/rme.12.90.

Autologous cell therapies: the importance of regulatory oversight.

Author information

1
Athersys, Inc., (NASDAQ: ATHX), 3201 Carnegie Avenue, Cleveland 44115-2653, OH, USA.

Abstract

Promising new medical technologies and approaches to treatment offer the potential to substantially improve the lives of patients who need help, and in some cases transform the way medicine is practiced. In recent years, the biotechnology industry has generated many examples of new approaches that are having a profound impact on medical care, including protein and peptide therapeutics, monoclonal antibodies and molecular diagnostics.

PMID:
23210820
DOI:
10.2217/rme.12.90
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Atypon
    Loading ...
    Support Center